GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC
Abroad (travel likely)Active Not RecruitingPHASE1, PHASE2
Conditions
HCC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Auckland Clinical Studies, Auckland, New Zealand